mpMRI with Flexible AIR Coil for Prostate Cancer
Trial Summary
What is the purpose of this trial?
Multiparametric MRI (mpMRI) of the prostate is an important tool for diagnosis of clinically significant prostate cancer (csPCa) in men with an elevated serum prostate specific antigen, which can decrease the rate of unnecessary biopsies and reduce the incidence of over-diagnosis of non-csPCa. Furthermore, there is evidence that MRI is more accurate in detecting high-grade (Gleason grade group ≥3) versus low grade cancers (Gleason grade group \<2) and therefore may serve as a useful adjunct to prostate-specific antigen (PSA) testing, digital rectal examination, and prostatic biopsy to detect cancers that require definitive treatment as opposed to active surveillance. Many investigators, including our group, have shown the utility of preoperative mpMRI to assess the local extent of prostate cancer and for surgical planning.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment using the Flexible AIR Coil for prostate cancer?
Research shows that using an endorectal coil in MRI scans can improve the detection and imaging quality of prostate cancer, helping doctors see the cancer more clearly. This suggests that similar coil technologies, like the Flexible AIR Coil, might also enhance imaging and aid in better diagnosis and treatment planning.12345
Is the mpMRI with Flexible AIR Coil for Prostate Cancer safe for humans?
The research on endorectal coils, which are similar to the Flexible AIR Coil, shows that they have been used safely in humans for imaging the prostate. These coils provide high-resolution images and have been tested in patients with prostate conditions, indicating they are generally safe for use.56789
How is the Flexible AIR Coil treatment for prostate cancer different from other treatments?
Research Team
Tharakeswara Bathala
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
Men over 18 with intermediate to high-risk prostate cancer that hasn't been treated yet. They must be eligible for a specific type of MRI scan and considering surgery within the next 6 months. Excluded are those with certain types of prostate cancer, prior treatments, or conditions like severe hemorrhoids, recent surgeries, other active cancers in the last two years, pacemakers, or claustrophobia.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Participants undergo mpMRI scans with either a flexible AIR coil or an endorectal coil
Follow-up
Participants are monitored for safety and effectiveness after imaging
Treatment Details
Interventions
- Endorectal Coil
- Flexible AIR Coil
Flexible AIR Coil is already approved in European Union, United States for the following indications:
- Diagnostic imaging for prostate cancer
- Assessment of local extent of prostate cancer
- Surgical planning
- Diagnostic imaging for prostate cancer
- Assessment of local extent of prostate cancer
- Surgical planning
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor